Description
Vyndamax 61 mg (tafamidis) Soft gelatin Capsule
Vyndamax is a once-daily, oral, reddish-brown capsule by Pfizer used to treat cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular mortality and hospitalization.
Manufacturer Pfizer Ltd
Composition: Tafamidis (61mg)
Storage: Store at below 30°C
Reviews
There are no reviews yet.